Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Molecular Weight | 298.98 g/mol |
---|---|
Molecular Formula | C6H7AgO7 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 297.92427 g/mol |
Monoisotopic Mass | 297.92427 g/mol |
Topological Polar Surface Area | 135 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 222 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
40
PharmaCompass offers a list of Silver Dihydrogen Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Silver Dihydrogen Citrate manufacturer or Silver Dihydrogen Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Silver Dihydrogen Citrate manufacturer or Silver Dihydrogen Citrate supplier.
PharmaCompass also assists you with knowing the Silver Dihydrogen Citrate API Price utilized in the formulation of products. Silver Dihydrogen Citrate API Price is not always fixed or binding as the Silver Dihydrogen Citrate Price is obtained through a variety of data sources. The Silver Dihydrogen Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Silver Dihydrogen Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Silver Dihydrogen Citrate, including repackagers and relabelers. The FDA regulates Silver Dihydrogen Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Silver Dihydrogen Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Silver Dihydrogen Citrate supplier is an individual or a company that provides Silver Dihydrogen Citrate active pharmaceutical ingredient (API) or Silver Dihydrogen Citrate finished formulations upon request. The Silver Dihydrogen Citrate suppliers may include Silver Dihydrogen Citrate API manufacturers, exporters, distributors and traders.
Silver Dihydrogen Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Silver Dihydrogen Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Silver Dihydrogen Citrate GMP manufacturer or Silver Dihydrogen Citrate GMP API supplier for your needs.
A Silver Dihydrogen Citrate CoA (Certificate of Analysis) is a formal document that attests to Silver Dihydrogen Citrate's compliance with Silver Dihydrogen Citrate specifications and serves as a tool for batch-level quality control.
Silver Dihydrogen Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Silver Dihydrogen Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Silver Dihydrogen Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Silver Dihydrogen Citrate EP), Silver Dihydrogen Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Silver Dihydrogen Citrate USP).